Proinflammatory Epstein–Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis
Annals of Neurology · 2026-09 · 100 (3) · 547-558
DOI: 10.1002/ana.78285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 17.06.2026. Verfasst von Malina Behrens und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Epstein-Barr Virus Nuclear Antigens, Herpesvirus 4, Human, Antibodies, Viral, Immunoglobulin G. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Epstein–Barr virus (EBV) has been implicated in the pathogenesis of multiple sclerosis (MS). Elevated immunoglobulin G (IgG) titers against EBV nuclear antigen 1 (EBNA1) represent the most consistent serological marker of MS risk, with levels remaining persistently elevated following disease onset.
Methods
We conducted high‐dimensional profiling of virus‐specific antibody‐associated immune features in 60 individuals with relapsing‐onset MS followed over time and in 54 age‐ and sex‐matched EBV‐seropositive healthy controls.
Results
EBNA1‐specific IgG in MS patients exhibited a distinct proinflammatory Fc signature, characterized by increased affinity for Fc γ receptors (FcγRs) and enhanced Fc‐mediated effector functions, including antibody‐dependent phagocytosis, complement activation, and natural killer cell engagement. This signature was not observed for antibodies against other common viral antigens and showed a strong association with MS. Increased FcγR binding by IgG, specific for both EBNA1 and the lytic EBV glycoprotein 350 (EBV‐gp350) correlated with disease activity, defined as clinical relapse and/or presence of contrast‐enhancing brain lesions (CELs).
Interpretation
Both fragment antigen‐binding and pro‐inflammatory functional Fc‐mediated features contribute to the association between EBNA1‐specific antibody responses and MS. Fc effector functions of EBV‐specific antibodies may actively participate in promoting focal disease activity in MS. ANN NEUROL 2026;100:547–558
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University Hospital Münster, Münster, Germany.
- Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
- Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Department of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.
- Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland.
- Servei de Neurologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)-ISCIII, CIBERNED, Madrid, Spain.
ORCID-Profile: Malina Behrens, Manuel Comabella, Jens Kuhle, Jan D Lünemann
Zitieren
APA
Behrens, M., Terroba-Navajas, P., Willemse, E. A. J., Schädelin, S., Comabella, M., Münz, C., Lauc, G., Bartsch, Y., Kuhle, J., & Lünemann, J. D. (2026). Proinflammatory Epstein–Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis. Annals of Neurology, 100(3), 547-558. https://doi.org/10.1002/ana.78285
Vancouver
Behrens M, Terroba-Navajas P, Willemse EAJ, Schädelin S, Comabella M, Münz C, et al. Proinflammatory Epstein–Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis. Annals of Neurology. 2026;100(3):547-558. doi:10.1002/ana.78285
BibTeX
@article{Behrens2026,
author = {Behrens, Malina and Terroba-Navajas, Paula and Willemse, Eline A J and Schädelin, Sabine and Comabella, Manuel and Münz, Christian and Lauc, Gordan and Bartsch, Yannic and Kuhle, Jens and Lünemann, Jan D},
title = {Proinflammatory Epstein–Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis},
journal = {Annals of Neurology},
year = {2026},
volume = {100},
number = {3},
pages = {547--558},
doi = {10.1002/ana.78285}
}
EUVIMED